Latin America & the Caribbean (IDA & IBRD countries) vs Netherlands: Antiretroviral therapy coverage

Latin America & the Caribbean (IDA & IBRD countries)
71.7%
in 2024
Netherlands
89.0%
in 2023
Latin America & the Caribbean (IDA & IBRD countries) rank
18th
Netherlands rank
21st

Antiretroviral therapy coverage over time

  • Latin America & the Caribbean (IDA & IBRD countries)
  • Netherlands
20406080200020122024

How they compare

Netherlands currently reports 89.0% against 71.7% in Latin America & the Caribbean (IDA & IBRD countries), a difference of 17.3%.

That makes Netherlands's figure about 1.2 times Latin America & the Caribbean (IDA & IBRD countries)'s.

Across all 24 years both countries report, Netherlands has been ahead every year.

Latin America & the Caribbean (IDA & IBRD countries) ranks 18th and Netherlands ranks 21st of 23 groups.

Netherlands has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Latin America & the Caribbean (IDA & IBRD countries) Netherlands Difference Ahead
2000s 21.0% 53.5% 32.5% Netherlands
2010s 48.7% 77.2% 28.5% Netherlands
2020s 67.3% 87.8% 20.5% Netherlands

Averages of every year both report within each decade.

Frequently asked questions

Which has higher antiretroviral therapy coverage, Latin America & the Caribbean (IDA & IBRD countries) or Netherlands?
Netherlands, at 89.0% against 71.7% in Latin America & the Caribbean (IDA & IBRD countries) as of 2023.
What is the difference in antiretroviral therapy coverage between Latin America & the Caribbean (IDA & IBRD countries) and Netherlands?
17.3%, with Netherlands ahead.
How many years of comparable data are there for Latin America & the Caribbean (IDA & IBRD countries) and Netherlands?
24 years are reported by both, from 2000 to 2023.
How do Latin America & the Caribbean (IDA & IBRD countries) and Netherlands rank globally for antiretroviral therapy coverage?
Latin America & the Caribbean (IDA & IBRD countries) ranks 18th and Netherlands ranks 21st of 23 groups.
Where does this data come from?
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Latin America & the Caribbean (IDA & IBRD countries) vs Netherlands: Antiretroviral therapy coverage. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 18 September 2026, from https://health.statizoid.com/compare/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/latin-america-and-the-caribbean-ida-and-ibrd-countries/netherlands/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/latin-america-and-the-caribbean-ida-and-ibrd-countries/netherlands/">Latin America & the Caribbean (IDA & IBRD countries) vs Netherlands: Antiretroviral therapy coverage</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage (% of people living with HIV)
Unit
% of people living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
166 places, 4,061 data points, 2000–2024
Last refreshed

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.